AI Analysis Reveals Surprising User Experiences with Unapproved Weight-Loss Drug Retatrutide
- Published
- Source
- ScienceDaily.com
An experimental weight-loss drug, retatrutide, is being used by individuals who obtain unapproved versions online. Researchers at the University of Pennsylvania utilized artificial intelligence to analyze nearly 150,000 Reddit posts from around 40,000 users, uncovering unexpected symptom reports that differ from those found in clinical trials.
The significance of this research lies in its potential to highlight discrepancies in user experiences compared to clinical trial findings. While retatrutide is designed to suppress appetite, the most common complaint among users was increased appetite, which contrasts sharply with the drug's intended effects and the side effects noted in Phase 2 trials.
Moving forward, researchers aim to explore these findings further, although they caution that the reports do not confirm new side effects. The study emphasizes the need for rigorous investigation into the experiences of individuals using unapproved versions of retatrutide, as they represent a population outside conventional drug safety monitoring.
Original report
People are taking an unapproved weight-loss drug. AI found something surprising
ScienceDaily.comThis briefing is an independently written summary based on publicly available reporting and is provided for industry information and news discovery. The original report and source publication are credited and linked where applicable. RobotToday does not claim ownership of third-party source material.
Rights concerns? Contact [email protected] with the relevant URL and details. We will review the matter and take appropriate action where warranted.
More related news
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- 10
- 11
- 12
Related Suppliers
University of Pennsylvania, GRASP Lab
Philadelphia, Pennsylvania robotics research center founded 1979 by Ruzena Bajcsy; 21,000 sq ft of lab space in Levine Hall and a Robotics MSE program.
Overland AI
Overland AI is a Seattle-based company developing off-road ground autonomy software and unmanned ground vehicles for US military and defense applications.
Bulwark Dynamics
Menlo Park defense startup founded 2025 building CARAVEL autonomous beach-landing resupply craft rated for 23,000 lb payload; USD 6.8M seed in 2026.
SKYROVER
Chinese consumer drone brand offering the SKYROVER X1 and S1 mini drones under 249g with 8K cameras, up to 15 km range, and AI obstacle sensing.
DreamVu
Philadelphia firm founded 2017 that captures real venues with its own single-shot 360-degree stereo camera and sells world-model and robot training data.
BioSensics
US-based developer of wearable sensors and digital health platforms for clinical trials and patient monitoring.
Andromeda Surgical
South San Francisco startup developing AI-powered autonomous surgical robots for endourology, starting with robotic HoLEP for benign prostatic hyperplasia.
Rapyuta Robotics
Tokyo cloud robotics company founded 2014 as ETH Zurich spinoff; makes PA-AMR pick-assist warehouse robots and the rapyuta.io multi-robot cloud platform.
Plus Automation
Japanese Robotics-as-a-Service provider making warehouse automation accessible via monthly-fee robot solutions.
Beijing Institute for General Artificial Intelligence 北京通用人工智能研究院
Beijing non-profit AGI institute led by Zhu Songchun whose embodied-AI stack includes the TongBrain robot brain and the open-source TongSIM simulator.
Shanghai Artificial Intelligence Laboratory 上海人工智能实验室
Shanghai-based national AI research institute founded 2020; develops the InternLM model family and the Intern-Robotics embodied-AI engine.
Learning Robots
Learning Robots is a Paris-Saclay CNRS spin-off making AlphAI, an educational robot and software for teaching artificial intelligence.
Robotics needs a service framework.
RSF defines a common language for robot service capability, lifecycle operations, certification pathways, and service-provider networks.
Join the RobotToday community on LinkedIn
Daily robotics news, in-depth analysis, conference highlights, and discussions with professionals worldwide.